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Background
Monocyte/macrophages are reservoirs capable of produ-
cing replication-competent HIV virions for many years
despite suppressive HAART. APOBEC3 proteins repre-
sent critical determinants of monocyte resistance to
HIV-1 infection, and their decreased expression during
macrophage differentiation results in a permissive target
cell population. Chemokines and their receptors are
deeply involved in HIV-1 infection control. Monocytes/
macrophages are the major source of CCL2 in vitro and
in vivo. Growing evidences suggest that CCL2 plays
important roles in AIDS pathogenesis. We previously
reported that CCL2 expression is up-regulated during
monocyte differentiation to macrophages and is further
increased in HIV-1 infected cells, where it acts as an
autocrine factor promoting HIV-1 replication. The aim
of this study was to investigate the mechanisms by
which CCL2 affects HIV-1 replication in macrophages.
Methods
Macrophages were differentiated from CD14+ mono-
cytes isolated from the peripheral blood of healthy
donors. Cells were treated with anti-CCL2 or control-
antibodies, and infected with HIV-1 BaL. Viral infection
was assessed by measuring total HIV-1 DNA by qPCR
and determining p24-Gag-antigen levels. VSV-G
pseudo-typed HIV-1 was used to investigate the effect
of CCL2 blocking on viral entry. APOBEC3 family
member and SAMHD1 mRNA and protein levels were
determined by qPCR and western-blot, respectively.
Results
We found that CCL2 neutralization induces a strong
reduction of HIV-1 DNA level 4 and 7 days post-
infection. The effect of anti-CCL2 Ab on viral DNA was
concentration-dependent and statistically significant
with respect to that of a control Ab. This effect corre-
lated with a strong reduction of the amount of p24 Gag
antigen positive macrophages. Since CCL2 blocking also
reduced infection with VSV-G pseudo-typed HIV-1,
inhibition of HIV-1 infection was not due to a block of
viral entry. Treatment of macrophages with anti-CCL2
Ab also resulted in induction of APOBEC3A expres-
sion, but did not affected the expression of the other
APOBEC3 family members and of SAMHD1. Further-
more, the presence of anti-CCL2 Ab reduced the per-
centage of p24 Gag Ag positive cells at similar extent
both in the absence and in the presence of exogenous
dNTPs, thus demonstrating that altered SAMHD1
expression or function cannot account for the CCL2
neutralization-mediated restriction of HIV-1 replica-
tion in macrophages.
Conclusions
Our data demonstrate that targeting CCL2 exerts its
antiviral effect at the level of viral DNA accumulation,
and that this effect may be linked to induction of APO-
BEC3A expression. The observation that CCL2 is an
endogenous negative regulator of APOBEC3A in macro-
phages highlights a new mechanism which may contri-
bute to the regulation of the expression of innate
intracellular viral antagonists in vivo. Thus, this study
will potentially lead to identification of new targets for
therapeutic intervention to prevent the onset of new
reservoirs cells.
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